Hey Warp, It was me. Twice in fact. I know it g
Post# of 30067
Posted On: 03/11/2015 2:14:00 PM
Hey Warp,
It was me. Twice in fact. I know it gets confusing for the DG. How do they keep track of who's who in "Group Think Gang", after all we all say the same thing... Oh wait...
"I am pleased to announce the appointments of such an esteemed trio of Alzheimer's researchers to Amarantus Diagnostics' inaugural Scientific Advisory Board," said Gerald E. Commissiong, President & CEO of Amarantus.
I believe that was AMBSDX's 3rd big move!
Amarantus Diagnostics
1) cornered the ALZ. market.
2) has a MSDX near ready for the Commercial market
3) assembled a DREAMTEAM of a SAB (to start with)
And January isn't even over yet!!!
Hahahha Cheers
Read More: http://investorshangout.com/post/view?id=2586...z3U6MzONIx
Chrisdc73,
Not only can't it be argued, and this is Only my opinion, but we have just made it Crystal clear that if you are running studies or are thinking about running studies, YOU WILL GO THROUGH US!
This team has the credibility to discredit studies that are looking for cures but failed or neglected to fully test their patient population properly!!!
To say we have " cornered " the market is a very polite way of saying, you will go through us if you are thinking about going to the FDA or CMS down the line.
Not only will we save you millions on your studies, we can potentially keep you from billions if you don't fully test your patients properly, because we have proof to show you're numbers will be skewed.
Yes, we are helping patients AND we are now playing hardball!!!
Just my 8 cents.
Cheers
Read More: http://investorshangout.com/post/view?id=2583...z3U6ND7Yhp
It was me. Twice in fact. I know it gets confusing for the DG. How do they keep track of who's who in "Group Think Gang", after all we all say the same thing... Oh wait...
"I am pleased to announce the appointments of such an esteemed trio of Alzheimer's researchers to Amarantus Diagnostics' inaugural Scientific Advisory Board," said Gerald E. Commissiong, President & CEO of Amarantus.
I believe that was AMBSDX's 3rd big move!
Amarantus Diagnostics
1) cornered the ALZ. market.
2) has a MSDX near ready for the Commercial market
3) assembled a DREAMTEAM of a SAB (to start with)
And January isn't even over yet!!!
Hahahha Cheers
Read More: http://investorshangout.com/post/view?id=2586...z3U6MzONIx
Chrisdc73,
Not only can't it be argued, and this is Only my opinion, but we have just made it Crystal clear that if you are running studies or are thinking about running studies, YOU WILL GO THROUGH US!
This team has the credibility to discredit studies that are looking for cures but failed or neglected to fully test their patient population properly!!!
To say we have " cornered " the market is a very polite way of saying, you will go through us if you are thinking about going to the FDA or CMS down the line.
Not only will we save you millions on your studies, we can potentially keep you from billions if you don't fully test your patients properly, because we have proof to show you're numbers will be skewed.
Yes, we are helping patients AND we are now playing hardball!!!
Just my 8 cents.
Cheers
Read More: http://investorshangout.com/post/view?id=2583...z3U6ND7Yhp
(0)
(0)